[1]唐茂盛 肖萌萌 陈小兵 刘世博 高海成 罗成华*.腹盆腔孤立性纤维性肿瘤的临床特征及手术疗效[J].中国微创外科杂志,2023,01(1):25-29.
　Tang Maosheng,Xiao Mengmeng,Chen Xiaobing,et al.Clinical Features and Surgical Outcomes of Solitary Fibrous Tumors in the Abdominal and Pelvic Cavity[J].Chinese Journal of Minimally Invasive Surgery,2023,01(1):25-29.
点击复制

腹盆腔孤立性纤维性肿瘤的临床特征及手术疗效()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2023年1期
页码:
25-29
栏目:
临床研究
出版日期:
2023-01-25

文章信息/Info

Title:
Clinical Features and Surgical Outcomes of Solitary Fibrous Tumors in the Abdominal and Pelvic Cavity
作者:
唐茂盛 肖萌萌 陈小兵 刘世博 高海成 罗成华*
(北京大学国际医院腹膜后肿瘤外科，北京102206)
Author(s):
Tang Maosheng;  Xiao Mengmeng;  Chen Xiaobing;  et al.
Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing 102206, China
关键词:
孤立性纤维性肿瘤; 腹膜后肿瘤
Keywords:
Solitary fibrous tumor; Retroperitoneal neoplasms
文献标志码:
A
摘要:
目的探讨腹盆腔孤立性纤维性肿瘤(solitary fibrous tumor，SFT)的临床特点及手术疗效。方法回顾性分析2015年4月~2022年1月35例腹盆腔SFT手术的临床资料。17例无明显症状，12例腰腹部或骶尾部疼痛，4例下肢肿痛，2例反复低血糖。肿瘤中位最大径15 cm(3~25 cm)。初次手术22例，复发再手术13例。结果R0或R1切除32例，R2切除3例。联合脏器切除6例。7例行分块切除。中位术中出血量1200 ml(50~10 000 ml)。术后并发症8例。随访3~68个月，中位数18个月。初次手术22例中4例复发，2例远处转移。结论手术完整切除是SFT最主要的治疗方法，术后易复发，需长期随访。
Abstract:
ObjectiveTo explore the clinical characteristics and treatment of solitary fibrous tumor (SFT) of abdominal and pelvic cavity.MethodsClinical data of 35 cases of abdominal and pelvic SFT surgery from April 2015 to January 2022 were retrospectively analyzed. Seventeen patients had no obvious symptoms, while 12 cases had waist, abdominal or sacrococcygeal pain, 4 cases had lower limb swelling and pain, and 2 cases had recurrent hypoglycemia. The median length of the tumor was 15 cm (range, 3-25 cm). There were 22 cases of primary surgery and 13 cases of reoperation for relapsed disease.ResultsThere were 32 cases of R0 or R1 resection and 3 cases of R2 resection. There were 6 cases combined with organ resection. In 7 cases the resection was performed in blocks. The median intraoperative blood loss was 1200 ml (range, 50-10 000 ml). There were 8 cases of postoperative complications. Followups lasted 3-68 months, with a median of 18 months. Among the 22 patients undergoing primary surgery, 4 had recurrence and 2 had distant metastasis.ConclusionComplete surgical resection is the most important treatment for SFT, which is prone to recurrence after surgery and requires longterm followups.

参考文献/References:

[1]Doyle LA.Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.Cancer,2014,120(12):1763-1774.
[2]Fletcher CD.The evolving classification of soft tissue tumours:an update based on the new 2013 WHO classification.Histopathology,2014,64(1):2-11.
[3]李文杰,苗成利,肖萌萌,等.腹盆部孤立性纤维性肿瘤的临床分析.中华普通外科杂志,2020,35(6):443-445.
[4]Gold JS,Antonescu CR,Hajdu C,et al.Clinicopathologic correlates of solitary fibrous tumors.Cancer,2002,94(4):1057-1068.
[5]刘坦坦,张兆祥,马世荣,等.恶性孤立性纤维性肿瘤的临床病理观察及文献复习.现代肿瘤医学,2017,25(10):1623-1628.
[6]孙萍萍,赵洪禹,王玲玲,等.腹膜后恶性孤立性纤维性肿瘤的临床病理分析.临床肿瘤学杂志,2020,25(1):54-58.
[7]Gholami S,Cassidy MR,Kirane A,et al.Size and location are the most important risk factors for malignant behavior in resected solitary fibrous tumors.Ann Surg Oncol,2017,24(13):3865-3871.
[8]Kallen ME,Hornick JL.The 2020 WHO classification:what’s new in soft tissue tumor pathology?Am J Surg Pathol,2021,45(1):e1-e23.
[9]Demicco EG,Wagner MJ,Maki RG,et al.Risk assessment in solitary fibrous tumors:validation and refinement of a risk stratification model.Mod Pathol,2017,30(10):1433-1442.
[10]Salas S,Resseguier N,Blay JY,et al.Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.Ann Oncol,2017,28(8):1979-1987.
[11]Gutierrez JC,Perez EA,Franceschi D,et al.Outcomes for softtissue sarcoma in 8249 cases from a large state cancer registry.J Surg Res,2007,141(1):105-114.
[12]安松林,闫风彩,赵爱民.恶性孤立性纤维性肿瘤11例临床诊治分析.中华普通外科杂志,2019,34(6):498-501.
[13]Kayani B,Sharma A,Sewell MD,et al.A review of the surgical management of extrathoracic solitary fibrous tumors.Am J Clin Oncol,2018,41(7):687-694.
[14]Wang Y,Wei R,Ji T,et al.Surgical treatment of primary solitary fibrous tumors involving the pelvic ring.PLoS One,2018,13(11):e0207581.
[15]Stacchiotti S,Saponara M,Frapolli R,et al.Patientderived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.Eur J Cancer,2017,76:84-92.
[16]Stacchiotti S,Libertini M,Negri T,et al.Response to chemotherapy of solitary fibrous tumour:a retrospective study.Eur J Cancer,2013,49(10):2376-2383.
[17]Kawamura S,Nakamura T,Oya T,et al.Advanced malignant solitary fibrous tumor in pelvis responding to radiation therapy.Pathol Int,2007,57(4):213-218.

备注/Memo

备注/Memo:
*通讯作者，Email：luochenghua@pkuih.edu.cn
更新日期/Last Update: 2023-04-23